Related by context. Frequent words. (Click for all words.) 68 Gestiva 63 Onsolis 60 Exalgo 59 ONSOLIS 58 Act PDUFA date 58 FENTORA 57 SILENOR TM 57 VIMOVO 56 alvimopan 55 NUVIGIL 55 pseudobulbar affect PBA 55 TOCOSOL Paclitaxel 55 OFIRMEV 54 Abstral 54 DRAXIS 54 BEMA Fentanyl 54 ATryn R 54 Relistor 54 LIALDA 53 Icatibant 53 Complete Response 53 PDUFA date 53 Zelrix 53 PhosLo 53 Tygacil 53 BLA submission 52 orBec R 52 NDA submission 52 InKine 52 Increlex 51 risks anduncertainties 51 commercialization milestones 51 pediatric exclusivity 51 KRYSTEXXA 51 PREOS 51 CUBICIN 51 Cellegy 51 Phase IIa clinical trials 51 Anturol 50 SANCTURA R 50 motavizumab 50 oral calcitonin 50 Bepreve 50 bazedoxifene 50 Investigational Device Exemption 50 Factive 50 Horizant 49 prGCD 49 Act PDUFA 49 Pirfenidone 49 Sabril 49 Entereg 49 Cimzia R 49 Indevus 49 Vilazodone 49 Complete Response letter 49 REPLAGAL 48 Biologics License Application BLA 48 Flutiform 48 pancreatic enzyme 48 alogliptin 48 GEM #S 48 Cinryze TM 48 Hycamtin 48 VPRIV 48 Mitigation Strategy REMS 48 confirmatory Phase III 48 FavId 48 Kuvan 48 Loramyc ® 48 Thyrogen 48 Marketing Authorization Application 48 Biologics License Application 48 Protopic 48 Microcyn Technology 48 Nasdaq VRTX 48 New Drug Application 48 NOXAFIL 48 chronic angina 48 ATryn 47 Mutual Recognition Procedure 47 FIRAZYR 47 CHMP opinion 47 Citizen Petition 47 orphan designation 47 Phase III clinical trials 47 SFDA approval 47 JZP 6 47 EPIX Pharmaceuticals 47 regadenoson 47 Neupro 47 Orphan Drug status 47 sNDA 47 approvability 47 Board DSMB 46 Drug Administration USFDA 46 European Medicines Evaluation 46 orphan medicinal product 46 Gabapentin GR 46 Complete Response Letter 46 Orphan Drug Status